NYSE · Healthcare · Statistics
AbbVie Inc. (ABBV) Valuation & Key Statistics
Valuation, profitability, balance-sheet health, and risk metrics for ABBV, refreshed each market session.
Section freshness
Prices as of Sep 8, 9:53 AM EDT · Fundamentals checked Sep 8, 9:30 AM EDT · Statements Jun 30, 2026
Key metrics at a glance
The numbers most investors check first
Market cap
$453.19B
P/E (TTM)
72.45
Forward P/E
—
FCF yield
4.02%
Return on equity
-106.32%
Dividend yield
2.70%
Valuation
- Market cap
- $453.19B
- Enterprise value
- $454.97B
- P/E (TTM)
- 72.45
- EPS (TTM)
- $3.54
Long-run compounding
CAGR since IPO and aggregate price growth.
Adjusted daily closes are annualized over the full price history; dividends are not included in this price-only return view.
- CAGR since IPO
- 20.34%
- From first adjusted close on January 2, 2013
- Aggregate CAGR
- 22.81%
- 1Y, 3Y, 5Y, 10Y blended CAGR
- First tracked close
- $20.42
- January 2, 2013
- History span
- 14 yrs
- Jan 2, 2013 to Sep 4, 2026 · 3,440 closes
- Latest tracked close
- $256.46
- September 4, 2026
- All-time high
- $267.47
- July 29, 2026
- All-time low
- $33.33
- January 10, 2013
- History source
- Long range
- Yahoo Finance
Valuation map
Risk and scale
Less volatile than the market
Pro formula stack
Ratios investors search for after the headline quote.
These are TECHi-computed from overview, income statement, balance sheet, and cash-flow rows when market-data sources expose the ingredients.
- FCF yield
- 4.02%
- TTM free cash flow / market cap
- FCF / share
- $10.30
- TTM free cash flow / shares outstanding
- Earnings yield
- 1.38%
- Inverse P/E
- TECHi quality score
- 3 / 7
- 7-point profitability, cash, leverage, and trend check
Quality and capital returns
TTM FCF / TTM net income
Balance-sheet and reinvestment reads
Total debt / TTM FCF
Distress and optionality read
ABBV Altman Z-score needs a fuller balance sheet.
TECHi computes a non-financial-company Altman-style score from working capital, retained earnings, EBIT, market value, liabilities, revenue, and assets. It is not a bankruptcy prediction, but it gives pro readers a fast stress screen that most quote pages do not show beside live valuation metrics.
- Net cash / share
- $-1.00
- Cash minus debt, per share
- Working capital
- -$7.97B
- Current assets minus current liabilities
- Debt growth YoY
- +324.26%
- Latest quarter vs same quarter last year
Valuation read
ABBV trades at 72.45× trailing earnings.
A trailing P/E above 30 means the market is paying up for ABBV. That premium has to be earned with above-average revenue or earnings growth.
Profitability
- Gross margin
- 129.21%
- Operating margin
- 51.51%
- Net margin
- 19.27%
- Return on equity
- -106.32%
- Return on assets
- 4.67%
- Current ratio
- 0.81
- >1 = covers near-term liabilities
- Beta (5Y)
- 0.28
Margin profile
Profitability read
ABBV converts 19.3% of revenue into net income.
Margins in the high single-digits to high-teens are the bulk of the index. The differentiated reads here are operating-margin direction (improving = leverage) and ROE — the latter tells you how much equity capital management actually needs.
Per-share & range
- Dividend yield
- 2.70%
- Forward yield
- Payout ratio
- 48.87%
- Dividend per share / EPS — lower leaves more room to grow
- Dividend coverage
- 5.96×
- TTM free cash flow / dividends paid — above 1× is self-funded
- Shares outstanding
- 1.77B
- 52w high
- $267.47
- 52w low
- $190.75
Corporate actions
Stock split history
Adjusted for all historical splits
- Split events
- 0
Reported fundamentals
Company statistics fields
These figures come from the latest issuer filings and live quote-derived formulas.
- Earnings growth YoY
- 290.38%
- TECHi unified data
- 50-day average
- $254.05
- TECHi unified data
- 200-day average
- $225.80
- TECHi unified data
- Dividend / share
- $1.73
- Yahoo Finance
- Ex-dividend date
- July 15, 2026
- Yahoo Finance
Frequently asked
Common questions.
What is AbbVie Inc.'s market capitalization?
AbbVie Inc. (ABBV) has a market capitalization of $453.2 billion.
What is ABBV's P/E ratio?
ABBV trades at a trailing price-to-earnings ratio of 72.45.
Where do TECHi's ABBV statistics come from?
ABBV statistics combine exchange quotes with company filings through TECHi's market-data providers. Any figure that is missing or out of date is left blank rather than estimated.